Variant report
Variant | nsv606990 |
---|---|
Chromosome Location | chr7:52724902-52750565 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529025358 | chr7:52725225-52725226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540577045 | chr7:52725246-52725247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551864027 | chr7:52725285-52725286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182993869 | chr7:52725316-52725317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534147085 | chr7:52725319-52725320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188443848 | chr7:52725344-52725345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77541508 | chr7:52725356-52725357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536538154 | chr7:52725369-52725370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201847121 | chr7:52725370-52725371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543817274 | chr7:52725371-52725372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116765689 | chr7:52725394-52725395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs576510003 | chr7:52725403-52725404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532490856 | chr7:52725420-52725421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192709364 | chr7:52725422-52725423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56164006 | chr7:52725425-52725426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183141545 | chr7:52725448-52725449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17135242 | chr7:52725488-52725489 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs547613858 | chr7:52725526-52725527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560915614 | chr7:52725552-52725553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200173099 | chr7:52725577-52725578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs66519216 | chr7:52725582-52725583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35105534 | chr7:52725583-52725584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74458432 | chr7:52725585-52725586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530051003 | chr7:52725655-52725656 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374978766 | chr7:52725699-52725700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543353976 | chr7:52725709-52725710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563200701 | chr7:52725761-52725762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531996855 | chr7:52725773-52725774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115065813 | chr7:52725775-52725776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10224969 | chr7:52725826-52725827 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs187677042 | chr7:52725856-52725857 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548093314 | chr7:52725896-52725897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34820754 | chr7:52725909-52725910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144137411 | chr7:52725950-52725951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536808094 | chr7:52725959-52725960 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73120124 | chr7:52725967-52725968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191203799 | chr7:52725973-52725974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539061949 | chr7:52725978-52725979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564244214 | chr7:52726005-52726006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147988067 | chr7:52726024-52726025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534804066 | chr7:52726028-52726029 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555001083 | chr7:52726029-52726030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150540142 | chr7:52726044-52726045 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543567683 | chr7:52726048-52726049 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114547834 | chr7:52726069-52726070 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs34489401 | chr7:52726102-52726103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73696273 | chr7:52726117-52726118 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs374643590 | chr7:52726143-52726144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576589527 | chr7:52726149-52726150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117397835 | chr7:52726214-52726215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Biliary cancer | 19435499 | CNVD |
Wilms tumour | 21544195 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 22495311 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastric cancer | 24379144 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Ovarian cancer | 18182111 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Barrett''s esophagus | 18559552 | CNVD |
head and neck squamous cell carcinoma | 16943533 | CNVD |
Anaplastic thyroid cancer | 17079354 | CNVD |
Basal-like breast cancer | 17875215 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Colorectal cancer | 18794099 | CNVD |
Gastrointestinal stromal cancer | 17643098 | CNVD |
Lung cancer | 18381415 | CNVD |
Metastatic colorectal cancer | 17664472 | CNVD |
Non-small cell lung cancer | 19255323 | CNVD |
Non-small cell lung cancer | 17673923 | CNVD |
Non-small cell lung cancer | 17975165 | CNVD |
Non-small cell lung cancer | 19622585 | CNVD |
Ovarian cancer | 16607561 | CNVD |
Squamous cell cancer | 19670535 | CNVD |
head and neck squamous cell carcinoma | 16818711 | CNVD |
small cell lung cancer | 18829487 | CNVD |
Breast cancer | 17661082 | CNVD |
Adenocarcinoma | 19260752 | CNVD |
Esophageal cancer | 16575012 | CNVD |
Lung adenocarcinoma | 19138956 | CNVD |
Lung adenocarcinoma | 18379350 | CNVD |
Lung adenocarcinoma | 18258923 | CNVD |
Lung cancer | 19138956 | CNVD |
Lung cancer | 18379350 | CNVD |
Lung cancer | 18258923 | CNVD |
Non-small cell lung cancer | 18304967 | CNVD |
Non-small cell lung cancer | 19451690 | CNVD |
Non-small cell lung cancer | 19260752 | CNVD |
Non-small cell lung cancer | 17079354 | CNVD |
Non-small cell lung cancer | 18559607 | CNVD |
Rectal cancer | 19506820 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
head and neck squamous cell carcinoma | 18813952 | CNVD |
Non-small cell lung cancer | 17504988 | CNVD |
Non-small cell lung cancer | 16943533 | CNVD |
Non-small cell lung cancer | 18509184 | CNVD |
head and neck squamous cell carcinoma | 17538160 | CNVD |
Colorectal cancer | 19712476 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Lung cancer | 19671679 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21990379 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:52725200-52725600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr7:52725400-52726000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr7:52725600-52726200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr7:52725600-52726600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr7:52726000-52727000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
6 | chr7:52726200-52726800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr7:52726600-52726800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr7:52726800-52727000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr7:52727000-52727200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr7:52731800-52732600 | Enhancers | HUVEC | blood vessel |
11 | chr7:52735600-52736400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr7:52736400-52736600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr7:52736600-52737000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr7:52737000-52737200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr7:52737600-52739000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr7:52738000-52739000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr7:52738200-52738600 | Enhancers | H9 Cell Line | embryonic stem cell |
18 | chr7:52738200-52739000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr7:52738200-52739000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr7:52738200-52739200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr7:52738200-52739200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr7:52738400-52739000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
23 | chr7:52738400-52739000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
24 | chr7:52738600-52739200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
25 | chr7:52739600-52739800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
26 | chr7:52739800-52746200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
27 | chr7:52746200-52746400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |